Toward 18 F-Labeled Theranostics: A Single Agent that Can Be Labeled with 18 F, 64 Cu, or 177 Lu.
Mathieu L LepageHsiou-Ting KuoÁron RoxinSungjoon HuhZhengxing ZhangRajaguru KandasamyHelen MerkensJoel O KumlinAlan LimogesStefan K ZeislerKuo-Shyan LinFrançois BénardDavid M PerrinPublished in: Chembiochem : a European journal of chemical biology (2019)
We report a single-molecule radiotracer that can be labeled independently with 18 F-fluoride or radiometals (64 Cu, 177 Lu) in a single step. A prostate-specific membrane antigen (PSMA)-targeting ligand, armed with both an organotrifluoroborate and a metal-chelator (DOTA), was designed to optionally afford 18 F-, 64 Cu- or 177 Lu-labeled products that were injected into mice bearing prostate cancer (LNCaP) xenografts. PET/CT images and ex vivo biodistribution data show high, specific tumor uptake irrespective of which radionuclide is used, thereby demonstrating a new approach to combining, in a single molecule, 18 F-labeling capabilities for PET imaging with radiometalation for potential imaging and therapeutic applications.
Keyphrases
- pet imaging
- single molecule
- pet ct
- prostate cancer
- positron emission tomography
- living cells
- atomic force microscopy
- computed tomography
- radical prostatectomy
- aqueous solution
- high resolution
- metal organic framework
- drinking water
- type diabetes
- optical coherence tomography
- drug delivery
- convolutional neural network
- metabolic syndrome
- risk assessment
- benign prostatic hyperplasia
- photodynamic therapy